See Our Latest Insights
on the impacts of COVID-19.

$81 Million

GenMark Diagnostics

Follow-on Offering

Lead Left Bookrunner, May 2020

GenMark is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.

More Like This

May 2020
$40 Million

Follow-on Offering

Lead Left Bookrunner

View Details
May 2020
$175 Million

Follow-on Offering

Lead Left Bookrunner

View Details
May 2020
$862 Million

Follow-on Offering

Bookrunner

View Details